In this article WBA Follow your favorite stocks CREATE FREE ACCOUNT In an aerial view, a customer enters a Walgreens store on January 04, 2024 in San Pablo, California. Justin Sullivan | Getty Images Shares of Walgreens plunged more than 14% on Thursday after the company reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook, citing a "challenging" environment for pharmacies and U.S.
consumers. The retail pharmacy giant now expects fiscal 2024 adjusted earnings of $2.80 to $2.
95 per share. That compares with the company's previous outlook of between $3.20 and $3.
35 per share. "'We assumed ..
. in the second half that the consumer would get somewhat stronger" but "that is not the case," Walgreens CEO Tim Wentworth told CNBC. He added that "the consumer is absolutely stunned by the absolute prices of things, and the fact that some of them may not be inflating doesn't actually change their resistance to the current pricing.
So we've had to get really keen, particularly in discretionary things." Still, Walgreens topped revenue estimates for the quarter on strong performance in its health-care segment. The company views that business division as critical to its ongoing push to transform from a major drugstore chain into a large health-care company.
The results come as Walgreens works to slash costs after a rocky last year marked by low pharmacy reimbursement rates, weakening demand for Covid products and a challengin.
